Workflow
SINYUAN ZM(301398)
icon
Search documents
A股限售股解禁一览:19.07亿元市值限售股今日解禁
Mei Ri Jing Ji Xin Wen· 2025-12-15 00:07
Summary of Key Points Core Viewpoint - On December 15, a total of 8 companies had their restricted shares unlocked, with a total unlock volume of 72.0354 million shares, amounting to a market value of 1.907 billion yuan based on the latest closing prices [1]. Group 1: Unlock Volume - Two companies had unlock volumes exceeding 10 million shares: Shengxin Lithium Energy with 46.6309 million shares and Aier Eye Hospital with 18.8905 million shares [1]. - Xingyuan Magnesium also had a significant unlock volume of 3.759 million shares [1]. Group 2: Unlock Market Value - Two companies had unlock market values exceeding 100 million yuan: Shengxin Lithium Energy with 1.398 billion yuan and Aier Eye Hospital with 210 million yuan [1]. - Xingyuan Magnesium's unlock market value was 181 million yuan [1]. Group 3: Unlock Ratio - In terms of the ratio of unlocked shares to total share capital, Shengxin Lithium Energy had the highest ratio at 5.09%, followed by Xingyuan Magnesium at 3.36% and Rongtai Co., Ltd. at 0.25% [1].
19.07亿元市值限售股今日解禁
Ge Long Hui· 2025-12-15 00:01
格隆汇12月15日|Wind数据显示,周一(12月15日),共有8家公司限售股解禁,合计解禁量为7203.54 万股,按最新收盘价计算,合计解禁市值为19.07亿元。从解禁量来看,2家公司解禁股数超千万股。盛 新锂能、爱尔眼科、星源卓镁解禁量居前,解禁股数分别为4663.09万股、1889.05万股、375.9万股。从 解禁市值来看,2家公司解禁股数超亿元。盛新锂能、爱尔眼科、星源卓镁解禁市值居前,解禁市值分 别为13.98亿元、2.1亿元、1.81亿元。从解禁股数占总股本比例来看,盛新锂能、星源卓镁、嵘泰股份 解禁比例居前,解禁比例分别为5.09%、3.36%、0.25%。 ...
星源卓镁(301398) - 2025年第二次临时股东大会决议公告
2025-12-12 11:32
| 证券代码:301398 | 证券简称:星源卓镁 | 公告编号:2025-067 | | --- | --- | --- | | 债券代码:123260 | 债券简称:卓镁转债 | | 宁波星源卓镁技术股份有限公司 2025 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 特别提示: 1. 本次股东大会未出现否决议案的情形; 2. 本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 (一)会议召开时间: 1.现场会议时间:2025年12月12日(星期五)14:30。 2.网络投票时间:通过深圳证券交易所交易系统进行网络投票的具体时间为: 2025年12月12日9:15-9:25,9:30-11:30,13:00-15:00;通过深圳证券交易所互联 网投票系统投票的具体时间为:2025年12月12日9:15-15:00期间的任意时间。 (二)会议召开地点:浙江省宁波市北仑区大碶街道璎珞河路139号四楼高 层会议室。 (三)会议召开方式:本次股东大会采取现场表决与网络投票相结合的方式 召开。 (四)会议召集人: ...
星源卓镁(301398) - 北京德恒律师事务所关于宁波星源卓镁技术股份有限公司2025年第二次临时股东大会的法律意见
2025-12-12 11:32
关于 宁波星源卓镁技术股份有限公司 2025 年第二次临时股东大会的 法律意见 北京市西城区金融街 19 号富凯大厦 B 座 12 层 电话:010-52682888 传真:010-52682999 邮编:100033 北京德恒律师事务所 根据《中华人民共和国证券法》(以下简称"《证券法》")、《中华人民共 和国公司法》(以下简称"《公司法》")、《上市公司股东会规则》(以下简称 "《股东会规则》")、《律师事务所从事证券法律业务管理办法》、《律师事务 所证券法律业务执业规则》(试行)等法律、法规和规范性文件的要求以及《宁 波星源卓镁技术股份有限公司章程》(以下简称"《公司章程》")的有关规定, 本所律师就本次股东大会的召集、召开程序,出席会议的人员资格、召集人资格, 提案审议情况,股东大会的表决方式、表决程序和表决结果等重要事项的合法性 进行了现场核验,现本所律师按照律师行业公认的业务标准、道德规范和勤勉尽 责精神,发表法律意见如下: 一、本次股东大会的召集、召开程序 星源卓镁2025年第二次临时股东大会经公司第三届董事会第十七次会议决 议 召 开 , 并 于 2025 年 11 月 27 日 在 上 海 ...
星源卓镁:公司将持续关注人形机器人行业技术发展趋势
Zheng Quan Ri Bao Wang· 2025-12-11 09:46
证券日报网讯12月11日,星源卓镁(301398)在互动平台回答投资者提问时表示,镁合金材料具有密度 低、比强度高、散热佳、成本优势显著等特点。公司将持续关注人形机器人行业技术发展趋势,若有相 关业务进展,将严格按照信息披露规则及时履行披露义务。 ...
星源卓镁(301398) - 国投证券股份有限公司关于宁波星源卓镁技术股份有限公司部分首次公开发行前已发行股份上市流通的专项核查意见
2025-12-10 10:58
国投证券股份有限公司 关于宁波星源卓镁技术股份有限公司 部分首次公开发行前已发行股份上市流通的专项核查意见 本次上市流通的限售股属于首次公开发行前已发行股份,除上述事项外,自 公司首次公开发行股票限售股形成至今,公司未发生因利润分配、公积金转增等 导致股本数量变动的情况。 截至本核查意见出具日,公司总股本为 112,000,000 股,其中有流通限制或 限售安排的股份数量为 78,540,000 股,占总股本的比例为 70.12%;无流通限制 及限售安排的股份数量 33,460,000 股,占总股本的比例为 29.88%。 国投证券股份有限公司(以下简称"国投证券"或"保荐机构")作为宁波 星源卓镁技术股份有限公司(以下简称"星源卓镁"或"公司")首次公开发行 股票并在创业板上市的保荐机构及持续督导机构,根据《证券发行上市保荐业务 管理办法》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务(2025 年修订)》《深圳证券交易所创业板股票上市规则(2025 年修订)》《深圳证券交 易所上市公司自律监管指引第 2 号——创业板上市公司规范运作(2025 年修订)》 等相关规定,对公司部分首次公开发行前 ...
星源卓镁(301398) - 关于部分首次公开发行前已发行股份上市流通提示性公告
2025-12-10 10:58
| 证券代码:301398 | 证券简称:星源卓镁 | 公告编号:2025-066 | | --- | --- | --- | | 债券代码:123260 | 债券简称:卓镁转债 | | 宁波星源卓镁技术股份有限公司 关于部分首次公开发行前已发行股份 特别提示: 1、本次解除限售的股份为宁波星源卓镁技术股份有限公司(以下简称"公 司"或"星源卓镁")部分首次公开发行前已发行股份。 2、本次解除股份限售的股东户数为 1 户,股份数量为 3,759,000 股,占公司 总股本的 3.36%,限售期为自公司首次公开发行并上市之日起 36 个月。 3、本次解除限售股份上市流通日期为 2025 年 12 月 15 日(星期一)。 4、本次解除股份限售的股东请勿在解限期间办理转托管、质押式回购等会 导致托管单元发生变更的业务,否则可能导致相应股东解除限售失败。 一、首次公开发行前已发行股份概况 (一)首次公开发行股份情况 根据中国证券监督管理委员会《关于同意宁波星源卓镁技术股份有限公司首 次公开发行股票注册的批复》(证监许可〔2022〕2084 号),公司首次公开发 行人民币普通股(A 股)股票 20,000,000 股 ...
星源卓镁:公司在定期报告中披露股东人数
Zheng Quan Ri Bao Wang· 2025-12-08 12:14
证券日报网讯12月8日,星源卓镁(301398)在互动平台回答投资者提问时表示,根据相关披露规则要 求,公司在定期报告中披露股东人数。 ...
卓镁转债投资价值分析:汽车轻量化,镁合金替代铝合金明确且加速
Shanxi Securities· 2025-12-08 05:13
Report Summary of Zhuomei Convertible Bond Investment Value Analysis 1. Report Industry Investment Rating No specific investment rating for the industry is provided in the report. 2. Core Viewpoints - The substitution of magnesium alloy for aluminum alloy in the automotive parts field is clear and accelerating, and Zhuomei Convertible Bond is currently overvalued but worthy of continuous attention [5][7] 3. Summary by Relevant Catalog Zhuomei Convertible Bond Information - Zhuomei Convertible Bond (123260.SZ) has a credit rating of A+, a bond balance of 450 million yuan, is a new bond with a remaining term of 5.93 years. The closing price on December 3 was 168.55 yuan, and the conversion premium rate was 81.76% [1] Star Source Zhuomei (Stock of Underlying Bond) Information - Star Source Zhuomei (301398.SZ) was established in 2003, focusing on the automotive lightweight field and applying magnesium alloy die - castings to body structural parts and interior parts. Its products include headlight heat dissipation frames, seat armrest skeletons, etc. From January to the third quarter of 2025, its revenue was 292 million yuan, a year - on - year increase of 1.48%; the net profit attributable to the parent was 45 million yuan, a year - on - year decrease of 19.63%. The actual controllers are Qiu Zhuoxiong and Lu Manfen, with a combined shareholding of 70.13%. The latest total market value is 5.432 billion yuan, and the expected PE in 2025 is 67.8x [3] Main Highlights of Zhuomei Convertible Bond - In the automotive parts field, the substitution of magnesium alloy for aluminum alloy is clear and accelerating. In May 2025, Seres completed the real - vehicle verification of an integrated die - cast magnesium alloy vehicle body, with a weight reduction of 21.8% compared to the aluminum alloy solution. The substitution is mainly due to the fact that the price of magnesium ingots has been lower than that of aluminum ingots, and the raw material cost of magnesium alloy for the same - volume parts is about 12.47% lower than that of aluminum alloy. Also, the breakthrough in semi - solid injection molding technology has reduced the oxidation risk of magnesium alloy and promoted its application in core structural parts [5] - The company's on - hand orders support high - growth performance in the next three years. Since 2021, the company has been deploying semi - solid magnesium alloy injection molding technology, and in November 2025, it obtained a 2.021 billion yuan fixed - point order from a domestic new energy vehicle company, planning to mass - produce magnesium alloy powertrain housing parts in the third quarter of 2026. As of November 2025, the company's cumulative magnesium alloy orders in the past year totaled 4.094 billion yuan [5] - The improvement in production capacity matches the order fulfillment. In July 2025, Yizumi delivered the UN6600MGII Plus equipment to the company, helping it break through the production bottleneck of complex structural parts and improve product yield. In November 2025, the company successfully issued convertible bonds to raise 450 million yuan, which is planned to be used entirely for the project of an annual production of 3 million sets of high - strength large - scale magnesium alloy precision - formed parts for automobiles [6] Valuation and Suggestion of Zhuomei Convertible Bond - Based on the Shanxi Securities convertible bond valuation model, without considering stock price changes and the changes of call and downward revision clauses, the reasonable valuation of Zhuomei Convertible Bond is between 147 - 154 yuan, and it is currently overvalued. However, since the remaining term of the bond is still long, it can be continuously monitored [7]
行业周报:人形机器人的“起跑时刻”,把握低位布局窗口-20251207
KAIYUAN SECURITIES· 2025-12-07 09:04
Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The humanoid robot sector continues to rebound, entering an upward channel, with the core company index rising by 5.54%, outperforming the broader market [12][11] - Multiple factors contributed to the unexpected strength of the rebound, including prior adjustments in the sector, advancements in Tesla's Optimus robot, and anticipated supportive policies from the U.S. government [4][12] - The year 2026 is projected to be a milestone for humanoid robot mass production, with significant catalysts expected [4][40] Summary by Sections Humanoid Robot Sector Performance - The humanoid robot sector index and leading stocks have shown a continued rebound, with the core company index increasing by 5.54% during the week of December 1 to December 5, 2025 [12][11] - The top five performers included Hengli Hydraulic (+11.53%), Siling Co. (+10.07%), and Wuzhou Xinchun (+9.24%) [12][14] Optimus Robot Development - Tesla's Optimus robot is progressing towards mass production, with recent demonstrations showcasing its running capabilities, achieving speeds of 2.5-3 m/s [5][16] - The U.S. government is expected to introduce supportive policies for the robot industry, which may accelerate development and enhance market confidence [31][33] - The domestic industrialization process is also speeding up, with leading companies preparing for capital market entry [34][38] Investment Opportunities - Key investment opportunities are identified in the supply chain, including components such as head assemblies, bearings, and structural parts [27][30] - Specific companies recommended for investment include Lens Technology, Minth Group, and Wuzhou Xinchun, among others [6][30] - The report emphasizes the importance of technological upgrades and supply chain integration to support mass production [27][30]